“Developing a medicine like that in general is a process that can take a decade and 2 billion dollars. Any process that we can use to speed up that long path will obviously do a lot for humanity,” explained the researcher.
Alan Aspuru AllMexican researcher at the University of Toronto, in an interview with EFEdeclared that artificial intelligence can speed up and make the development of a possible drug once morest liver cancer faster and cheaper.
The Mexican is considered one of the most prominent researchers in modern chemistry, and his use of the artificial intelligence for his investigations surprised everyone.
“More accessible medicine”
That’s what’s fabulous. Artificial intelligence sped up that initial process, which typically takes six months to a year, to a month. That encourages us that if we continue to use artificial intelligence in other areas of drug development, we can continue to compressing the timeslowering costs and making medicine more accessible,” he declared.
Aspuru Guzik’s team used the artificial intelligence (AI) systems PandaOmics, AlphaFord and Chemistry42 to make the discovery.
The Mexican researcher pointed out that the first AI they used made it possible to identify weak points in hepatocellular carcinoma cancer proteins.
“Developing a medicine like that in general is a process that can take a decade and 2 billion dollars. Any process that we can use to speed up that long path will obviously do a lot for humanity,” explained the researcher.
YOU MAY ALSO BE INTERESTED IN: Meta Announces Monthly Subscription Plan Called Meta Verified
